Actavis, Others Plotted To Delay Generic Namenda, Suit Says
Actavis PLC and other pharmaceutical companies were hit with a proposed class action in New York federal court Monday over an alleged scheme to delay generic versions of the Alzheimer's drug...To view the full article, register now.
Already a subscriber? Click here to view full article